Literature DB >> 6438681

Cerebral and blood pharmacokinetics of imipramine and its active metabolites in the pregnant rat.

C L DeVane, J W Simpkins, S A Stout.   

Abstract

A single IP dose of imipramine (IMI) was administered to pregnant rats. Whole blood, plasma, and brain concentrations of IMI, desipramine (DMI), and their 2-hydroxylated metabolites were separated by high-pressure liquid chromatography and quantified by fluorescence detection. IMI and DMI rapidly appeared in brain tissue in concentrations greatly exceeding those in whole blood and plasma. The much higher concentration and longer persistence of DMI in brain compared to IMI suggests that the predominant central effects from administered IMI result from biotransformation to DMI. The metabolite: "parent" area under the curve ratios for the hydroxylated metabolites indicate that their contribution to the pharmacologic effects of IMI and DMI are probably negligible.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6438681     DOI: 10.1007/bf00427450

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  24 in total

1.  Pharmacokinetics of red blood cell phenothiazine and clinical effects. Acute dystonic reactions.

Authors:  D L Garver; J M Davis; H Dekirmenjian; F D Jones; R Casper; J Haraszti
Journal:  Arch Gen Psychiatry       Date:  1976-07

2.  Plasma and erythrocyte levels of tricyclic antidepressants in depressed patients.

Authors:  M Linnoila; F Dorrity; K Jobson
Journal:  Am J Psychiatry       Date:  1978-05       Impact factor: 18.112

3.  High-performance liquid chromatographic assay for imipramine, desipramine, and their 2-hydroxylated metabolites.

Authors:  T A Sutfin; W J Jusko
Journal:  J Pharm Sci       Date:  1979-06       Impact factor: 3.534

4.  Statistical moments in pharmacokinetics.

Authors:  K Yamaoka; T Nakagawa; T Uno
Journal:  J Pharmacokinet Biopharm       Date:  1978-12

5.  Hydroxylated metabolites of tricyclic antidepressants: preclinical assessment of activity.

Authors:  W Z Potter; H M Calil; A A Manian; A P Zavadil; F K Goodwin
Journal:  Biol Psychiatry       Date:  1979-08       Impact factor: 13.382

6.  First-pass metabolism of imipramine in man.

Authors:  L F Gram; J Christiansen
Journal:  Clin Pharmacol Ther       Date:  1975-05       Impact factor: 6.875

7.  Plasma levels of tricyclic antidepressants and clinical efficacy: review of the literature -- part II.

Authors:  S C Risch; L Y Huey; D S Janowsky
Journal:  J Clin Psychiatry       Date:  1979-02       Impact factor: 4.384

8.  Metabolism of 5-hydroxytryptamine and levels of tricyclic antidepressant drugs in rat brain after acute and chronic treatment.

Authors:  M van Wijk; J J Meisch; J Korf
Journal:  Psychopharmacology (Berl)       Date:  1977-12-28       Impact factor: 4.530

9.  SPECIES DIFFERENCES IN THE METABOLISM OF IMIPRAMINE AND DESMETHYLIMIPRAMINE (DMI).

Authors:  J V DINGELL; F SULSER; J R GILLETTE
Journal:  J Pharmacol Exp Ther       Date:  1964-01       Impact factor: 4.030

10.  Phenothiazine levels in plasma and red blood cells. Their relationship to clinical improvement in schizophrenia.

Authors:  R Casper; D L Garver; H Dekirmenjian; S Chang; J M Davis
Journal:  Arch Gen Psychiatry       Date:  1980-03
View more
  5 in total

Review 1.  Prenatal antidepressant exposure: clinical and preclinical findings.

Authors:  Chase H Bourke; Zachary N Stowe; Michael J Owens
Journal:  Pharmacol Rev       Date:  2014-02-24       Impact factor: 25.468

2.  Steady-state kinetics of imipramine in transgenic mice with elevated serum AAG levels.

Authors:  J W Holladay; M J Dewey; S D Yoo
Journal:  Pharm Res       Date:  1996-09       Impact factor: 4.200

Review 3.  Pharmacokinetic optimisation of tricyclic antidepressant therapy.

Authors:  M Furlanut; P Benetello; E Spina
Journal:  Clin Pharmacokinet       Date:  1993-04       Impact factor: 6.447

4.  Facilitation of imipramine efflux from the brain by systemic specific antibodies.

Authors:  C Ragusi; G Boschi; R Rips; J M Scherrmann
Journal:  Br J Pharmacol       Date:  1996-08       Impact factor: 8.739

5.  Antidepressant stimulation of CDP-diacylglycerol synthesis does not require monoamine reuptake inhibition.

Authors:  Marwa A Aboukhatwa; Ashiwel S Undieh
Journal:  BMC Neurosci       Date:  2010-01-27       Impact factor: 3.288

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.